Prescribers would discuss risks before certain first pain prescriptions, with exceptions for cancer treatment, licensed hospice or palliative care, long-term healthcare facility residents, and addiction-treatment medicines.
Prescribers would explain risks and possible alternatives before certain first pain prescriptions and document specific topics. Exceptions cover cancer treatment, licensed hospice or palliative care, long-term healthcare facility residents, and medicines used to treat substance abuse or opioid dependence.
Prescribers would discuss addiction and overdose, dangerous drug combinations, other risks, why the medicine is needed, and possible alternatives. They would record that they discussed dependence risks and possible alternatives. The rules would cover initial prescriptions for acute or chronic pain involving Schedule II controlled drugs or other prescription opioid pain relievers. Schedule II is a legal category of controlled drugs. Prescribers would speak with the patient, or the patient's parent if the patient is a minor. Patients currently in cancer treatment, receiving hospice care from a licensed hospice or palliative care, or living in a long-term healthcare facility would be exempt. Medicines prescribed to treat substance abuse or opioid dependence would also be exempt. The discussion would occur before the initial prescription. If enacted, the requirements would take effect after publication in the statute book, the official collection of laws.
No hearings or votes scheduled.